Skip to main content
    X

    X4 Pharmaceuticals Inc (XFOR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.09
    +0.26 (+9.19%)

    Market Cap: $288.98M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    X4 Pharmaceuticals Inc (XFOR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    X4 Pharmaceuticals (XFOR) has a latest price of $3.09 on Nov 17, 2026, 36.0% below its 52-week high of $4.83. Its price fell 15.6% over the past 12 months. The month-end price fell 99.9% since Nov 2017, a compound annual decline of 53.4%.

    Price Chart

    From Nov 2017 to Oct 2026, its highest month-end close was $4,123.50 in Mar 2018 and its lowest $1.68 in Jul 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart XFOR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XFOR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 25.7%, and over 6 months it fell 15.1%. The month-end price fell 86.1% over the 3 years through Oct 2026, a compound annual decline of 48.2%.

    PeriodChange
    1 month+12.4%
    3 months-25.7%
    6 months-15.1%
    12 months-15.6%
    12 months, with dividends-15.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-86.1%-48.2%
    5 years-97.7%-53.0%
    Since Nov 2017-99.9%-53.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price fell 12.5%, and its weakest was 2025, when it fell 81.8%.

    YearCloseChange
    2026 through Oct 2026$3.35-16.2%
    2025$4.00-81.8%
    2024$22.03-12.5%
    2023$25.18-15.6%
    2022$29.82-56.6%
    2021$68.77-64.4%
    2020$193.09-39.9%
    2019$321.32-23.1%
    2018$417.93-81.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 0.9% below its 50-day average of $3.12 and 18.0% below its 200-day average of $3.77.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.09
    52-week high$4.83-36.0%
    52-week low$2.43+27.2%
    50-day average$3.12-0.9%
    200-day average$3.77-18.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 96.8%.

    MeasureValue
    1-year beta1.59
    Largest fall, 1 year-47.5%
    Largest fall, 3 years-96.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About XFOR

    What is XFOR's 1-year price change?

    X4 Pharmaceuticals's price fell 15.6% over the past 12 months. With dividends included, the 12-month total return was -15.6%.

    What is XFOR's 5-year price change?

    X4 Pharmaceuticals's month-end price fell 97.7% over the 5 years through Oct 2026, a compound annual decline of 53.0%. These figures leave out dividends.

    What is XFOR's 52-week high and low?

    X4 Pharmaceuticals's 52-week high is $4.83 and its 52-week low is $2.43. Its latest price of $3.09 on Nov 17, 2026 is 36.0% below the high.

    What is XFOR's beta?

    X4 Pharmaceuticals's 1-year beta against the S&P 500 is 1.59, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 47.5%.

    Is the XFOR chart free?

    Yes. Advanced Charting for XFOR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.